Epitranscriptomics in Hematopoiesis and Hematologic Malignancies
نویسندگان
چکیده
منابع مشابه
The Notch signaling pathway in hematopoiesis and hematologic malignancies.
Iron Metabolism & Its Disorders Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo Igor Theurl, Andrea Schroll, Manfred Nairz, Markus Seifert, Milan Theurl, Thomas Sonnweber, Hasan Kulaksiz, and Guenter Weiss Leukemogenesis MLL-ENL leukemia burden initiated in femoral diaphysis and preceded by mature B-cell depletion Agnieszka Jara...
متن کاملFungal Infections in Pediatric Patients with Hematologic Malignancies
As the data on the epidemiology and outcome of fungal infections in children with hematologic cancer are limited especially in Iran, this study was aimed to delineate the epidemiologic features and outcome of fungal infections in this population. The medical records of all children with hematologic malignancies diagnosed with a fungal infection from 2005 to 2010 at a tertiary pediatric hospita...
متن کاملHematologic Malignancies
Touch MEdical MEdia 43 Multiple myeloma (MM) is an incurable plasma cell disease that comprises 1 % of all cancers and 10 % of hematologic malignancies. It primarily affects older individuals—the median age at the moment of diagnosis is 70 years—and two-thirds of multiple myeloma patients are over 65 years of age when they are first diagnosed. The outcome of MM patients has significantly improv...
متن کاملCD44 and hematologic malignancies.
The expression of CD44 was upregulated in some hematological malignancies and is associated with metastasis and prognosis. The ligation of CD44 with specific monoclonal antibodies can trigger terminal differentiation of leukemic blasts in some subtypes, so it is probable to develop an anti-CD44 based differentiation therapy in leukemia. The effects of CD44 and its monoclonal antibodies are disc...
متن کاملHematologic Malignancies in Pregnancy
Cancer and especially hematological cancer during pregnancy is infrequent and its management is difficult for patients and their families, but also for their physicians since two lives with different priorities have to be considered. Treatment should adhere the standard treatment for the specific type and stage of cancer. Small adaptations can be considered in order to avoid adverse effects on ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Blood Cancer Discovery
سال: 2020
ISSN: 2643-3230,2643-3249
DOI: 10.1158/2643-3249.bcd-20-0032